214 related articles for article (PubMed ID: 16913648)
1. A comprehensive approach to Parkinson's disease. How to manage fluctuating motor and nonmotor symptoms.
Brunton S
Postgrad Med; 2006; 119(1):55-64. PubMed ID: 16913648
[TBL] [Abstract][Full Text] [Related]
2. Parkinson's Disease.
Reich SG; Savitt JM
Med Clin North Am; 2019 Mar; 103(2):337-350. PubMed ID: 30704685
[TBL] [Abstract][Full Text] [Related]
3. Tremor and dopamine agonists.
Elble RJ
Neurology; 2002 Feb; 58(4 Suppl 1):S57-62. PubMed ID: 11909986
[TBL] [Abstract][Full Text] [Related]
4. [Motor symptoms in Parkinson disease].
Larsen JP; Beiske AG; Bekkelund SI; Dietrichs E; Tysnes OB; Vilming ST; Aasly JO
Tidsskr Nor Laegeforen; 2008 Sep; 128(18):2068-71. PubMed ID: 18846123
[TBL] [Abstract][Full Text] [Related]
5. Medical management of levodopa-associated motor complications in patients with Parkinson's disease.
Jankovic J; Stacy M
CNS Drugs; 2007; 21(8):677-92. PubMed ID: 17630819
[TBL] [Abstract][Full Text] [Related]
6. Levodopa/carbidopa/entacapone in Parkinson's disease.
Seeberger LC; Hauser RA
Expert Rev Neurother; 2009 Jul; 9(7):929-40. PubMed ID: 19589043
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and Treatment of Parkinson Disease: A Review.
Armstrong MJ; Okun MS
JAMA; 2020 Feb; 323(6):548-560. PubMed ID: 32044947
[TBL] [Abstract][Full Text] [Related]
8. Early Parkinson's disease: what is the best approach to treatment.
Hristova AH; Koller WC
Drugs Aging; 2000 Sep; 17(3):165-81. PubMed ID: 11043817
[TBL] [Abstract][Full Text] [Related]
9. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.
Bracco F; Battaglia A; Chouza C; Dupont E; Gershanik O; Marti Masso JF; Montastruc JL;
CNS Drugs; 2004; 18(11):733-46. PubMed ID: 15330687
[TBL] [Abstract][Full Text] [Related]
10. Drugs for Parkinson's disease.
Treat Guidel Med Lett; 2013 Nov; 11(135):101-6. PubMed ID: 24165688
[TBL] [Abstract][Full Text] [Related]
11. Modern therapy of Parkinson's disease.
Ransmayr G; Künig G; Gerstenbrand F
J Neural Transm Suppl; 1992; 38():129-40. PubMed ID: 1491245
[TBL] [Abstract][Full Text] [Related]
12. Treatment of advanced Parkinson's disease.
Diamond A; Jankovic J
Expert Rev Neurother; 2006 Aug; 6(8):1181-97. PubMed ID: 16893346
[TBL] [Abstract][Full Text] [Related]
13. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
Parkinson Study Group
JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889
[TBL] [Abstract][Full Text] [Related]
14. [Direct switch from conventional levodopa to stalevo (levodopa/carbidopa/entacapone) improves quality of life in Parkinson's disease: results of an open-label clinical study].
Litvinenko IV; Odinak MM; Mogil'naia VI; Sologub OS; Sakharovskaia AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(1):51-4. PubMed ID: 19156087
[TBL] [Abstract][Full Text] [Related]
15. New concepts in the treatment of Parkinson's disease.
Ahlskog JE; Wilkinson JM
Am Fam Physician; 1990 Feb; 41(2):574-84. PubMed ID: 1967895
[TBL] [Abstract][Full Text] [Related]
16. Parkinson Disease.
Halli-Tierney AD; Luker J; Carroll DG
Am Fam Physician; 2020 Dec; 102(11):679-691. PubMed ID: 33252908
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Parkinson's disease.
Lieberman A
Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):339-43. PubMed ID: 8507903
[TBL] [Abstract][Full Text] [Related]
18. Identifying poor symptom control in Parkinson's disease.
Scott L
Nurs Times; 2006 Mar 21-27; 102(12):30-2. PubMed ID: 16594560
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacological treatment of parkinsonian tremor].
Yokochi F
Nihon Rinsho; 2000 Oct; 58(10):2091-5. PubMed ID: 11068452
[TBL] [Abstract][Full Text] [Related]
20. Emerging drugs for Parkinson's disease.
Morgan JC; Sethi KD
Expert Opin Emerg Drugs; 2006 Sep; 11(3):403-17. PubMed ID: 16939381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
